— Know what they know.
Not Investment Advice

SWAV NASDAQ

ShockWave Medical, Inc.
1W: +0.2% 1M: +1.4% 3M: +28.3% 1Y: +21.2% 3Y: +90.6% 5Y: +448.7%
$334.75
Last traded 2024-05-30 — delisted
NASDAQ · Healthcare · Medical - Devices · $12.6B mcap · 37M float · 3.47% daily turnover
Smart Money Score
No convergence signal
Key Statistics
Market Cap$12.6B
52W Range157.0-334.9
Volume3,947,054
Avg Volume1,301,576
Beta0.88
Dividend—
Analyst Ratings
4 Buy 8 Hold 1 Sell
Consensus Hold
Company Info
CEODouglas E. Godshall
Employees1,468
SectorHealthcare
IndustryMedical - Devices
IPO Date2019-03-07
5403 Betsy Ross Drive
Santa Clara, CA 95054
US
510 279 4262
About ShockWave Medical, Inc.

ShockWave Medical, Inc. is a medical technology firm that specializes in the development and global commercialization of intravascular lithotripsy (IVL) systems. This innovative approach is designed to treat calcified plaque in individuals affected by peripheral vascular, coronary vascular, and heart valve conditions. The company's product offerings include the M5 catheter for addressing above-the-knee peripheral artery disease, the C2 catheter specifically for coronary artery disease, and the S4 catheter, which targets below-the-knee peripheral artery disease. ShockWave Medical serves a professional clientele, including interventional cardiologists, vascular surgeons, and interventional radiologists, leveraging both direct sales teams and distribution partners. The organization was founded in 2009 and is based in Santa Clara, California.

Latest News
No recent news

Recent Insider Trades

NameTypeSharesPriceDate
Zacharias Isaac D-Return 29,588 — 2024-05-31
Godshall Douglas Eva D-Return 100,810 — 2024-05-31
FRANCIS LAURA D-Return 13,690 $6.59 2024-05-31
MOLL FREDERIC H D-Return 17,381 $17.00 2024-05-31
WATKINS FRANK T D-Return 84,313 $3.42 2024-05-31

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms